Transmission of Mycobacterium tuberculosis in China: A Population-Based Molecular Epidemiologic Study

Clinical Infectious Diseases

Volumn 61, Issue 2, 2015, Pages 219-227

  Yang, Chongguang ^a   Shen, Xin ^b   Peng, Ying ^c   Lan, Rushu ^d   Zhao, Yuling ^e   Long, Bo ^f   Luo, Tao ^a   Sun, Guomei ^a   Li, Xia ^a   Qiao, Ke ^a   Gui, Xiaohong ^b   Wu, Jie ^b   Xu, Jiying ^e   Li, Fabin ^c   Li, Dingyue ^f   Liu, Feiying ^d   Shen, Mei ^b   Hong, Jianjun ^g   Mei, Jian ^b   Deriemer, Kathryn ^h   Gao, Qian ^a   more..

^a FUDAN UNIVERSITY   (China)

^b Harbin Municipal Center for Disease Control and Prevention   (China)

^c Tuberculosis Control Center of Heilongjiang Province   (China)

^d Guangxi Zhuang Autonomous Region Center for Disease Control and Prevention   (China)

^e CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^f Sichuan Center for Disease Control and Prevention   (China)

^g Songjiang District Center for Disease Control and Prevention   (China)

^h UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

molecular epidemiology; recent transmission; China; tuberculosis

Indexed keywords

ISONIAZID; RIFAMPICIN; BACTERIAL DNA; TUBERCULOSTATIC AGENT;

ADULT; ARTICLE; BACTERIAL STRAIN; BACTERIAL TRANSMISSION; CHINA; DRUG SENSITIVITY; FEMALE; GENOTYPE; HUMAN; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; RISK; RISK FACTOR; SPUTUM SMEAR; TANDEM REPEAT; AGED; CLUSTER ANALYSIS; GENETICS; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MIDDLE AGED; MOLECULAR EPIDEMIOLOGY; ODDS RATIO; REGRESSION ANALYSIS; SPUTUM; STATISTICS AND NUMERICAL DATA; TIME FACTOR; TRANSMISSION; TUBERCULOSIS, MULTIDRUG-RESISTANT; TUBERCULOSIS, PULMONARY; URBAN POPULATION; VARIABLE NUMBER OF TANDEM REPEAT;

ADULT; AGED; ANTITUBERCULAR AGENTS; BEIJING; CHINA; CLUSTER ANALYSIS; DNA, BACTERIAL; FEMALE; GENOTYPE; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MINISATELLITE REPEATS; MOLECULAR EPIDEMIOLOGY; MYCOBACTERIUM TUBERCULOSIS; ODDS RATIO; REGRESSION ANALYSIS; RISK FACTORS; SPUTUM; TIME FACTORS; TUBERCULOSIS, MULTIDRUG-RESISTANT; TUBERCULOSIS, PULMONARY; URBAN POPULATION;

EID: 84936773800     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/civ255     Document Type: Article

References (34)

1. Sails AD, Barrett A, Sarginson S, et al. Molecular epidemiology of Mycobacterium tuberculosis in east Lancashire 2001-2009. Thorax 2011; 66:709-13.
2. Small PM, Hopewell PC, Singh SP, et al. The epidemiology of tuberculosis in San Francisco. A population-based study using conventional and molecular methods. N Engl J Med 1994; 330:1703-9.
3. Barnes PF, Cave MD. Molecular epidemiology of tuberculosis. N Engl J Med 2003; 349:1149-56.
4. Alland D, Kalkut GE, Moss AR, et al. Transmission of tuberculosis in New York City. An analysis by DNA fingerprinting and conventional epidemiologic methods. N Engl J Med 1994; 330:1710-6.
5. Kato-Maeda M, Small PM. How molecular epidemiology has changed what we know about tuberculosis. West J Med 2000; 172:256-9.
6. Godfrey-Faussett P, Sonnenberg P, Shearer SC, et al. Tuberculosis control and molecular epidemiology in a South African gold-mining community. Lancet 2000; 356:1066-71.
7. World Health Organization (WHO). Global tuberculosis report 2013. Geneva, Switzerland: WHO, 2014. Available at: http://www.who.int/ tb/publications/global-report/en/. Accessed 6 April 2015.
8. Giesecke J. Modern infectious disease epidemiology. 2nd ed. London: Arnold Press, 2002:268.
9. Wang L, Zhang H, Ruan Y, et al. Tuberculosis prevalence in China, 1990-2010; a longitudinal analysis of national survey data. Lancet 2014; 383:2057-64.
10. Tang S, Ping H. New features and controlling strategies of tuberculosis in the new century in China. Chin J Pract Intern Med 2011; 6:403-5.
11. World Health Organization (WHO). Anti-tuberculosis drug resistance in the world: third global report. Geneva, Switzerland: WHO, 2004: WHO/HTM/TB/2004.343.
12. Lan R, Yang C, Lan L, et al. Mycobacterium tuberculosis and nontuberculous mycobacteria isolates from HIV-infected patients in Guangxi, China. Int J Tuberc Lung Dis 2011; 15:1669-75.
13. Chen J, Tsolaki AG, Shen X, Jiang X, Mei J, Gao Q. Deletion-targeted multiplex PCR (DTM-PCR) for identification of Beijing/W genotypes of Mycobacterium tuberculosis. Tuberculosis (Edinb) 2007; 87:446-9.
14. Luo T, Yang C, Pang Y, Zhao Y, Mei J, Gao Q. Development of a hierarchical variable-number tandem repeat typing scheme for Mycobacterium tuberculosis in China. PLoS One 2014; 9:e89726.
15. Allix-Beguec C,Wahl C, Hanekom M, et al. Proposal of a consensus set of hypervariable mycobacterial interspersed repetitive-unit-variablenumber tandem-repeat loci for subtyping of Mycobacterium tuberculosis Beijing isolates. J Clin Microbiol 2014; 52:164-72.
16. Behr MA, Warren SA, Salamon H, et al. Transmission of Mycobacterium tuberculosis from patients smear-negative for acid-fast bacilli. Lancet 1999; 353:444-9.
17. Tostmann A, Kik SV, Kalisvaart NA, et al. Tuberculosis transmission by patients with smear-negative pulmonary tuberculosis in a large cohort in the Netherlands. Clin Infect Dis 2008; 47:1135-42.
18. Hernandez-Garduno E, Cook V, Kunimoto D, Elwood RK, BlackWA, FitzGerald JM. Transmission of tuberculosis from smear negative patients: a molecular epidemiology study. Thorax 2004; 59: 286-90.
19. Cronin WA, Golub JE, Lathan MJ, et al. Molecular epidemiology of tuberculosis in a low-to moderate-incidence state: are contact investigations enough? Emerg Infect Dis 2002; 8:1271-9.
20. Glynn JR, Crampin AC, Yates MD, et al. The importance of recent infection with Mycobacterium tuberculosis in an area with high HIV prevalence: a long-term molecular epidemiological study in northern Malawi. J Infect Dis 2005; 192:480-7.
21. Middelkoop K, Bekker LG, Mathema B, et al. Molecular epidemiology of Mycobacterium tuberculosis in a South African community with high HIV prevalence. J Infect Dis 2009; 200:1207-11.
22. Borgdorff MW, van den Hof S, Kalisvaart N, Kremer K, van Soolingen D. Influence of sampling on clustering and associations with risk factors in the molecular epidemiology of tuberculosis. Am J Epidemiol 2011; 174:243-51.
23. Yang C, Luo T, Sun G, et al. Mycobacterium tuberculosis Beijing strains favor transmission but not drug resistance in China. Clin Infect Dis 2012; 55:1179-87.
24. Cowley D, Govender D, February B, et al. Recent and rapid emergence of W-Beijing strains of Mycobacterium tuberculosis in Cape Town, South Africa. Clin Infect Dis 2008; 47:1252-9.
25. Wada T, Fujihara S, Shimouchi A, et al. High transmissibility of the modern Beijing Mycobacterium tuberculosis in homeless patients of Japan. Tuberculosis (Edinb) 2009; 89:252-5.
26. Portevin D, Gagneux S, Comas I, Young D. Human macrophage responses to clinical isolates from the Mycobacterium tuberculosis complex discriminate between ancient and modern lineages. PLoS Pathog 2011; 7:e1001307.
27. Moonan PK, Teeter LD, Salcedo K, et al. Transmission of multidrugresistant tuberculosis in the USA: a cross-sectional study. Lancet Infect Dis 2013; 13:777-84.
28. Anderson LF, Tamne S, Brown T, et al. Transmission ofmultidrug-resistant tuberculosis in the UK: a cross-sectional molecular and epidemiological study of clustering and contact tracing. Lancet Infect Dis 2014; 14:406-15.
29. Zhao Y, Xu S, Wang L, et al. National survey of drug-resistant tuberculosis in China. N Engl J Med 2012; 366:2161-70.
30. He GX, Wang HY, Borgdorff MW, et al. Multidrug-resistant tuberculosis, People's Republic of China, 2007-2009. Emerg Infect Dis 2011; 17:1831-8.
31. Mehra M, Cossrow N, Kambili C, Underwood R, Makkar R, Potluri R. Assessment of tuberculosis burden in China using a dynamic disease simulation model. Int J Tuberc Lung Dis 2013; 17:1186-94.
32. Lohmann E, Koster B, le Cessie S, Kamst-van Agterveld M, van Soolingen D, Arend S. Grading of a positive sputum smear and the risk of Mycobacterium tuberculosis transmission. Int J Tuberc Lung Dis 2012; 16:1477-84.
33. Perkins M, Small P. Partnering for better microbial diagnostics. Nat Biotechnology 2006; 24:919-21.
34. Murray M. Sampling bias in the molecular epidemiology of tuberculosis. Emerg Infect Dis 2002; 8:363-9.